BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
  • Homepage
  • Online Submission
Number of total visits
195490
Number of visits today
2
Number of downloads
47609
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Wohlmuth-Wieser I, Alhusayen R. Treatment of hidradenitis suppurativa with certolizumab pegol during pregnancy. Int J Dermatol 2021;60:e140-1. [PMID: 33247833 DOI: 10.1111/ijd.15286] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Repetto F, Burzi L, Ramondetta A, Rozzo G, Licciardello M, Ribero S, Quaglino P, Dapavo P. Certolizumab pegol and its role in pregnancy-age hidradenitis suppurativa. Int J Dermatol 2021. [PMID: 34270087 DOI: 10.1111/ijd.15742] [Reference Citation Analysis]
2 Amat-Samaranch V, Agut-Busquet E, Vilarrasa E, Puig L. New perspectives on the treatment of hidradenitis suppurativa. Ther Adv Chronic Dis 2021;12:20406223211055920. [PMID: 34840709 DOI: 10.1177/20406223211055920] [Reference Citation Analysis]
3 Scala E, Cacciapuoti S, Garzorz-Stark N, Megna M, Marasca C, Seiringer P, Volz T, Eyerich K, Fabbrocini G. Hidradenitis Suppurativa: Where We Are and Where We Are Going. Cells 2021;10:2094. [PMID: 34440863 DOI: 10.3390/cells10082094] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2022 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345